{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:31:07Z","timestamp":1778081467426,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40262-023-01249-z","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T07:02:37Z","timestamp":1685343757000},"page":"1011-1022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Population Pharmacokinetic Model of Pentobarbital for Children with Status Epilepticus and Severe Traumatic Brain Injury"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0382-5337","authenticated-orcid":false,"given":"Naomi","family":"Ketharanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Lili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia M. Penning","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enno D.","family":"Wildschut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"de Hoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit C. P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda C. M.","family":"de Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"issue":"4","key":"1249_CR1","first-page":"329","volume":"1","author":"F L\u00f3pez-Mu\u00f1oz","year":"2005","unstructured":"L\u00f3pez-Mu\u00f1oz F, Ucha-Udabe R, Alamo C. The history of barbiturates a century after their clinical introduction. Neuropsychiatr Dis Treat. 2005;1(4):329\u201343.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"1249_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jpeds.2011.04.021","volume":"159","author":"AF Zuppa","year":"2011","unstructured":"Zuppa AF, et al. Population pharmacokinetics of pentobarbital in neonates, infants, and children after open heart surgery. J Pediatr. 2011;159(3):414-419 e1-3.","journal-title":"J Pediatr"},{"issue":"6","key":"1249_CR3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/0897190017743130","volume":"31","author":"DM Hensler","year":"2018","unstructured":"Hensler DM, et al. Pentobarbital removal during continuous venovenous hemofiltration: case report and review of the literature. J Pharm Pract. 2018;31(6):682\u20136.","journal-title":"J Pharm Pract"},{"issue":"10","key":"1249_CR4","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00381-017-3520-0","volume":"33","author":"N Ketharanathan","year":"2017","unstructured":"Ketharanathan N, et al. Analgosedation in paediatric severe traumatic brain injury (TBI): practice, pitfalls and possibilities. Childs Nerv Syst. 2017;33(10):1703\u201310.","journal-title":"Childs Nerv Syst"},{"issue":"6","key":"1249_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/0883073811424941","volume":"27","author":"M Barberio","year":"2012","unstructured":"Barberio M, et al. Continuous infusion pentobarbital for refractory status epilepticus in children. J Child Neurol. 2012;27(6):721\u20136.","journal-title":"J Child Neurol"},{"issue":"6","key":"1249_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/FTD.0000000000000217","volume":"37","author":"RM Humble","year":"2015","unstructured":"Humble RM, et al. Therapeutic drug monitoring of pentobarbital: experience at an Academic Medical Center. Ther Drug Monit. 2015;37(6):783\u201391.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"1249_CR7","doi-asserted-by":"publisher","first-page":"R112","DOI":"10.1186\/cc6999","volume":"12","author":"J P\u00e9rez-B\u00e1rcena","year":"2008","unstructured":"P\u00e9rez-B\u00e1rcena J, et al. Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: a randomized controlled trial. Crit Care. 2008;12(4):R112.","journal-title":"Crit Care"},{"issue":"3","key":"1249_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0887-8994(01)00311-3","volume":"25","author":"SJ Kim","year":"2001","unstructured":"Kim SJ, Lee DY, Kim JS. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol. 2001;25(3):217\u201320.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"1249_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy GM, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3\u201323.","journal-title":"Neurocrit Care"},{"issue":"1","key":"1249_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/adc.79.1.78","volume":"79","author":"RC Tasker","year":"1998","unstructured":"Tasker RC. Emergency treatment of acute seizures and status epilepticus. Arch Dis Child. 1998;79(1):78\u201383.","journal-title":"Arch Dis Child"},{"issue":"3","key":"1249_CR11","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1186\/cc13883","volume":"18","author":"D Pugin","year":"2014","unstructured":"Pugin D, et al. Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Crit Care. 2014;18(3):R103.","journal-title":"Crit Care"},{"issue":"7","key":"1249_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s00063-019-00610-0","volume":"114","author":"F Erbguth","year":"2019","unstructured":"Erbguth F. [Management of refractory and super-refractory status epilepticus] Management des refrakt\u00e4ren und superrefrakt\u00e4ren Status epilepticus. Med Klin Intensivmed Notfmed. 2019;114(7):628\u201334.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"4","key":"1249_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0022-3476(82)80780-4","volume":"100","author":"DH Schaible","year":"1982","unstructured":"Schaible DH, et al. High-dose pentobarbital pharmacokinetics in hypothermic brain-injured children. J Pediatr. 1982;100(4):655\u201360.","journal-title":"J Pediatr"},{"issue":"2","key":"1249_CR14","first-page":"275","volume":"69","author":"GT Marshall","year":"2010","unstructured":"Marshall GT, et al. Pentobarbital coma for refractory intra-cranial hypertension after severe traumatic brain injury: mortality predictions and one-year outcomes in 55 patients. J Trauma. 2010;69(2):275\u201383.","journal-title":"J Trauma"},{"issue":"3","key":"1249_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/PCC.0b013e318271c3b2","volume":"14","author":"SA Mellion","year":"2013","unstructured":"Mellion SA, et al. High-dose barbiturates for refractory intracranial hypertension in children with severe traumatic brain injury. Pediatr Crit Care Med. 2013;14(3):239\u201347.","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"1249_CR16","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1097\/CCM.0000000000000507","volume":"42","author":"MS Vavilala","year":"2014","unstructured":"Vavilala MS, et al. Acute care clinical indicators associated with discharge outcomes in children with severe traumatic brain injury. Crit Care Med. 2014;42(10):2258\u201366.","journal-title":"Crit Care Med"},{"issue":"3","key":"1249_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jpeds.2011.05.041","volume":"159","author":"AA Vinks","year":"2011","unstructured":"Vinks AA. Important role of population pharmacokinetic\/pharmacodynamic modeling in pediatric therapeutics. J Pediatr. 2011;159(3):361\u20133.","journal-title":"J Pediatr"},{"issue":"1","key":"1249_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1164\/rccm.201510-2114OC","volume":"194","author":"NJ Vet","year":"2016","unstructured":"Vet NJ, et al. Inflammation and organ failure severely affect midazolam clearance in critically ill children. Am J Respir Crit Care Med. 2016;194(1):58\u201366.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"1249_CR19","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s40262-021-01064-4","volume":"60","author":"C Lenoir","year":"2021","unstructured":"Lenoir C, et al. Impact of inflammation on cytochromes P450 activity in pediatrics: a systematic review. Clin Pharmacokinet. 2021;60(12):1537\u201355.","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"1249_CR20","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832\u201343.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"1249_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00134-014-3391-8","volume":"40","author":"DT Selewski","year":"2014","unstructured":"Selewski DT, et al. Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population. Intensive Care Med. 2014;40(10):1481\u20138.","journal-title":"Intensive Care Med"},{"issue":"6","key":"1249_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","volume":"157","author":"V Sharma","year":"2009","unstructured":"Sharma V, McNeill JH. To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol. 2009;157(6):907\u201321.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1249_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","volume":"82","author":"MO Karlsson","year":"2007","unstructured":"Karlsson MO, Savic RM. Diagnosing model diagnostics. Clin Pharmacol Ther. 2007;82(1):17\u201320.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1249_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1208\/s12248-012-9320-2","volume":"14","author":"M Joerger","year":"2012","unstructured":"Joerger M. Covariate pharmacokinetic model building in oncology and its potential clinical relevance. Aaps J. 2012;14(1):119\u201332.","journal-title":"Aaps J"},{"issue":"9","key":"1249_CR25","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1023\/A:1011970125687","volume":"15","author":"EN Jonsson","year":"1998","unstructured":"Jonsson EN, Karlsson MO. Automated covariate model building within NONMEM. Pharm Res. 1998;15(9):1463\u20138.","journal-title":"Pharm Res"},{"issue":"6","key":"1249_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/j.1552-4604.1997.tb04326.x","volume":"37","author":"EI Ette","year":"1997","unstructured":"Ette EI. Stability and performance of a population pharmacokinetic model. J Clin Pharmacol. 1997;37(6):486\u201395.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"1249_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, et al. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. Aaps J. 2011;13(2):143\u201351.","journal-title":"Aaps J"},{"issue":"1","key":"1249_CR28","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/PCC.0b013e3181fe406d","volume":"13","author":"NJ Vet","year":"2012","unstructured":"Vet NJ, et al. The effect of critical illness and inflammation on midazolam therapy in children. Pediatr Crit Care Med. 2012;13(1):e48-50.","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"1249_CR29","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/epi.14447","volume":"59","author":"BS Moffett","year":"2018","unstructured":"Moffett BS, et al. Phenobarbital population pharmacokinetics across the pediatric age spectrum. Epilepsia. 2018;59(7):1327\u201333.","journal-title":"Epilepsia"},{"issue":"12","key":"1249_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053439","volume":"7","author":"VC De Souza","year":"2012","unstructured":"De Souza VC, et al. Schwartz formula: is one k-coefficient adequate for all children? PLoS ONE. 2012;7(12): e53439.","journal-title":"PLoS ONE"},{"issue":"3","key":"1249_CR31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/apa.15557","volume":"110","author":"G Filler","year":"2021","unstructured":"Filler G, et al. How should we assess renal function in neonates and infants? Acta Paediatr. 2021;110(3):773\u201380.","journal-title":"Acta Paediatr"},{"issue":"11","key":"1249_CR32","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s00467-017-3852-8","volume":"33","author":"G Filler","year":"2018","unstructured":"Filler G, Lee M. Educational review: measurement of GFR in special populations. Pediatr Nephrol. 2018;33(11):2037\u201346.","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"1249_CR33","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s00467-017-3704-6","volume":"32","author":"LT Filho","year":"2017","unstructured":"Filho LT, et al. Accuracy of neutrophil gelatinase-associated lipocalin for acute kidney injury diagnosis in children: systematic review and meta-analysis. Pediatr Nephrol. 2017;32(10):1979\u201388.","journal-title":"Pediatr Nephrol"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01249-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-023-01249-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01249-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T15:30:25Z","timestamp":1689175825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-023-01249-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1249"],"URL":"https:\/\/doi.org\/10.1007\/s40262-023-01249-z","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"30 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest and source of funding"}},{"value":"The datasets generated during and\/or analysed during the current study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}